等待開盤 08-27 09:30:00 美东时间
-0.015
-1.42%
PharmaCyte Biotech ( ($PMCB) ) has issued an update. On August 17, 2025, Pharma...
08-18 21:48
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly earnings of $1.54 per share. This is a 566.67 percent increase over losses of $(0.33) per share from the same period last year.
08-11 21:44
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
05-28 05:06
PharmaCyte Biotech (NASDAQ:PMCB) announced a $7 million investment in MyMD Pharmaceuticals (NASDAQ:MYMD), a clinical stage biopharmaceutical company committed to developing novel therapies for age-rel...
2024-05-21 21:16
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
Femasys Secures $6.85M Additional Financing With Strategic Investment From Inve...
2023-11-15 08:32
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunitiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company")
2023-10-31 21:22
On Tuesday, 386 stocks made new 52-week lows.
2023-09-27 00:04
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get...
2023-04-13 04:42
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares traded up 0.4% on Tu...
2023-03-31 04:02